1Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J ]. N Engl J Med, 2003 ; 348 : 1546.
2Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi[J ]. Lancet, 2002,359:1135.
3Potter M. European experience with oral solution and intravenous itraconazole[ J ]. Oncology ,2001,15( 11 Suppl 9) :27.
4Boogaerts M, Winston DJ, Bow EJ, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy[J ]. Ann Intern Med,2001 ; 135:412.
6Parfitt K. Martindale The complete drug reference [ M].32nd ed. Pharmaceutical press, 1999;381.
7De Beule K, Van Gestel J. Pharmacology of itraconazole [ J ].Drugs ,2001,61(Suppl 1) :27.
8Caillot D, Bassaris H, Seifert WF, et al. Efficacy, safety and pharmacokinetics of intravenous followed by oral itraconazole in patients with invasive pulmonary aspergillosis [ J ]. Antimicrob Agents Chemother , 1999,9:26.
9Estey E. Reducing mortality associated with immediate treatment complications of adult leukemias[ J ]. Semin-Hemato1,2001,38(4Suppl 10) :32.
10Caillot D, 13assarls H, MeGeer A, et al. Intravenous itraconazole followed by oral itmconazole in the treatment of invasive pulmonary aspergillesis in patients with hematologic malignancies,chronic granulornatous disease, or AIDS [ J ]. Clin Infect Dis,2001,15,33(8) : e83.
8Karel DB,Jef VGPharmacology of itraconazoleDrugs,2001,61(1):27.
9Vijaya DB,Kishore KH,Vidya PP,et al.Development and validation of a highly sensitive and robust LC MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma:Application to a bioequivalence study.J Chromatogr B,2008,868:70.
10Tomoya O,Kazuki N,Susumu N,et al.Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects.J Clin Pharmacol.2008,48 ( 3 ) :330.
